Biochemistry, Genetics and Molecular Biology
Polo-Like Kinase
100%
Genome Instability
98%
DNA Damage
98%
Cancer Cell
85%
Cell Cycle
66%
Homologous Recombination
66%
DNA Damage Response
52%
DNA Repair
52%
Kinase
42%
Phosphotransferase
42%
DNA Damage Checkpoint
40%
Cisplatin
37%
DNA Replication
37%
BRCA1
35%
BRCA2
34%
S Phase
33%
Dynamics
32%
Cyclin E1
31%
Poly ADP Ribose Polymerase
30%
Anaphase-Promoting Complex
28%
Gene Expression
27%
P53
26%
Epidermal Growth Factor Receptor
26%
Cytotoxicity
24%
Cell Cycle Checkpoint
24%
Oncogene
23%
Poly ADP Ribose Polymerase
21%
RAD51
20%
Chromosome Instability
17%
Cell Cycle Progression
16%
Cell Cycle Arrest
16%
Messenger RNA
16%
Wee1
16%
Quantitative Proteomics
15%
Carcinogenesis
15%
Oxidative Phosphorylation
14%
Immunocompetent Cell
14%
MUC1
14%
Helicase
14%
DNA Synthesis
14%
Chromatin Remodeling
14%
Mitosis
13%
Tumor Suppressor Gene
13%
Genetic Screen
13%
Genetics
12%
Mouse
11%
Ataxia Telangiectasia and Rad3 Related
10%
Drive
10%
Transcription
10%
Interphase
10%
Medicine and Dentistry
Neoplasm
46%
Cancer Cell
46%
Malignant Neoplasm
39%
Ovarian Cancer
38%
Cisplatin
31%
Homologous Recombination
26%
Molecular Imaging
22%
Genomic Instability
21%
PARP Inhibitor
21%
DNA Repair
18%
DNA Damage
17%
Breast Cancer
16%
DNA Damage Response
16%
Xenograft
15%
Testis Cancer
14%
BRCA1
12%
Disease
11%
Gamma Urogastrone
11%
Treatment Response
10%
Radiation Therapy
10%
Rectum Cancer
10%
Neoadjuvant Therapy
9%
Signal Transduction
9%
Triple Negative Breast Cancer
9%
S Phase
8%
Epidermal Growth Factor Receptor
8%
Oncogene
8%
Cancer Therapy
8%
Tumor Cell
8%
Patient Selection
8%
Head and Neck Squamous Cell Carcinoma
8%
BRCA2
8%
Diffuse Large B-Cell Lymphoma
8%
Colorectal Cancer
8%
Biological Marker
7%
Metastatic Carcinoma
7%
Cancer Model
7%
Personalized Medicine
7%
Recombination Repair
7%
Cytotoxicity
7%
Cell Cycle
7%
Radiosensitivity
7%
Oncology
7%
Genetic Screen
7%
Carboplatin
7%
Head and Neck Cancer
7%
cGAS-STING signaling pathway
7%
Immunocompetent Cell
7%
Beta1 Integrin
7%
Antibody-Drug Conjugate
7%
Keyphrases
Polo-like Kinase 1 (PLK1)
32%
DNA Damage
27%
CGAS-STING
24%
Cancer Cells
19%
Genomic Instability
18%
Inflammatory Pathways
17%
Carboplatin
14%
PARylation
14%
Cisplatin Sensitivity
14%
Ovarian Cancer
14%
Wee1 Inhibitors
14%
CtIP
14%
Homologous Recombination
13%
Cisplatin
11%
Cancer Treatment
10%
Mitosis
10%
DNA Damage Response
10%
Replication Stress
9%
Cyclic GMP-AMP Synthase (cGAS)
9%
Cyclin E1
8%
Sigma Phase
8%
DNA Repair
8%
Replication Speed
8%
In Cancer
8%
High-grade Serous Ovarian Cancer (HGSOC)
8%
Overexpression
8%
Chromosomal Instability
7%
BRCA1, BRCA2
7%
Homologous Recombination Defect
7%
Re-resection
7%
Breast Cancer Susceptibility Gene 1 (BRCA1)
7%
Tumor Cells
7%
Checkpoint Control
7%
Mammalian Cells
7%
Power Supply
7%
Protein Phosphatase
7%
Cell Cycle Re-entry
7%
Volume 14
7%
EGFR Inhibition
7%
Concurrent Chemoradiotherapy
7%
RNA Stabilization
7%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
7%
Novel Therapeutics
7%
FIGNL1
7%
Therapeutic Potential
7%
Rb Protein
7%
Feedback Network
7%
Mitotic Phosphorylation
7%
Magnesium
7%
Testicular Cancer
7%